Similar Defects ID'd for T2DM, Chronic Pancreatitis and Diabetes

Share this content:
Similar Defects ID'd for T2DM, Chronic Pancreatitis and Diabetes
Similar Defects ID'd for T2DM, Chronic Pancreatitis and Diabetes

WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- Patients with type 2 diabetes and those with diabetes secondary to chronic pancreatitis have similarly impaired α-cell responses to oral glucose ingestion and hypoglycemia, according to a study published online July 27 in Diabetes Care.

Lena Mumme, from St. Josef Hospital in Bochum, Germany, and colleagues compared 10 patients with diabetes secondary to chronic pancreatitis with 13 patients with type 2 diabetes and 10 healthy controls. Participants underwent stepwise hypoglycemic clamp and an oral glucose tolerance test (OGTT).

The researchers found that patients with diabetes and chronic pancreatitis had higher glucose levels during the OGTT, while levels were lower in controls (P < 0.0001). In both groups with diabetes, insulin and C-peptide levels were reduced, and glucose-induced suppression of glucagon was impaired (all P < 0.0001 versus controls). In patients with chronic pancreatitis and with type 2 diabetes, glucagon concentrations were reduced during hypoglycemia (P < 0.05). There was an inverse relationship between the increase in glucagon during the clamp and the glucose-induced glucagon suppression, and a positive relationship with β-cell function. In patients with type 2 diabetes, but not those with chronic pancreatitis, growth hormone responses to hypoglycemia were lower (P = 0.0002).

"α-cell responses to oral glucose ingestion and to hypoglycemia are disturbed in patients with diabetes and chronic pancreatitis and in patients with type 2 diabetes," the authors write. "The similarities between these defects suggest a common etiology."

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

High Costs Associated With Physician Burnout, Attrition

High Costs Associated With Physician Burnout, Attrition

Economic loss at Stanford over two years expected to range from $15.5 million to $55.5 million

Insulin Doesn't Prevent Diabetes in Relatives of T1DM Patients

Insulin Doesn't Prevent Diabetes in Relatives of T1DM ...

Oral insulin doesn't delay onset in autoantibody-positive relatives of patients with type 1 diabetes

Workplace Sexual Harassment Ongoing in Women, Up for Men

Workplace Sexual Harassment Ongoing in Women, Up for ...

Women report more adverse effects after SH than men, but SH can trigger depression, anxiety in men

is free, fast, and customized just for you!

Already a member?

Sign In Now »